(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 21.14% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.62%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.3%.
Glaukos's revenue in 2024 is $314,711,000.On average, 9 Wall Street analysts forecast GKOS's revenue for 2024 to be $17,613,004,171, with the lowest GKOS revenue forecast at $17,529,349,686, and the highest GKOS revenue forecast at $17,708,432,617. On average, 9 Wall Street analysts forecast GKOS's revenue for 2025 to be $22,151,519,718, with the lowest GKOS revenue forecast at $20,322,449,768, and the highest GKOS revenue forecast at $27,574,319,076.
In 2026, GKOS is forecast to generate $29,061,498,932 in revenue, with the lowest revenue forecast at $23,439,086,417 and the highest revenue forecast at $36,300,406,989.